Vaccine and Treatment Evaluation Units: Clinical Trial Implementation and Assays to Support a Phase II Influenza Vaccine Trial

疫苗和治疗评估单位：支持 II 期流感疫苗试验的临床试验实施和分析

• 批准号: 10709839
• 负责人: LISA JACKSON
• 金额: $ 0.5万
• 依托单位: KAISER FOUNDATION HEALTH PLAN OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-28 至 2023-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10709839
• 关键词: Biological Assay; Birds; Clinical Trials Unit; Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Influenza A Virus, H5N1 Subtype; Influenza A virus; Phase; Population; Resources; Special Population; Vaccine Clinical Trial; Vaccines; clinical trial implementation; combat; design; influenza virus vaccine; programs; vaccine trial

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该项目由学术中心和组织内的个别合同组成，为临床试验的设计和实施提供现成的资源，以评估有前途的产品，以对抗传染病。一般来说，产品将在正常健康人群中进行评估；但是，也可以接触到特殊人群。